Variation in severity of respiratory syncytial virus infections with subtype

Two major subtypes of respiratory syncytial virus have been identified. This study assessed the hypothesis that A-subtype infections were more severe than B-subtype infections among the 157 infants hospitalized in two hospitals in Rochester, N.Y., during two winters. Severity was measured both by sp...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pediatrics Vol. 117; no. 1; pp. 52 - 62
Main Authors McConnochie, Kenneth M., Hall, Caroline B., Walsh, Edward E., Roghmann, Klaus J.
Format Journal Article
LanguageEnglish
Published United States Mosby, Inc 01.07.1990
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Two major subtypes of respiratory syncytial virus have been identified. This study assessed the hypothesis that A-subtype infections were more severe than B-subtype infections among the 157 infants hospitalized in two hospitals in Rochester, N.Y., during two winters. Severity was measured both by specific clinical observations and by a severity index that was derived empirically. Among all subjects, several clinical observations suggested that A-subtype infections were more severe. For example, mechanical ventilation was required in 12.6% of those with A-subtype compared with 1.6% of those with B-subtype infection (relative risk=7.88; p=0.01). Among high-risk infants (infants with underlying conditions or age 3 months or less at admission), carbon dioxide tension greater than 45 mm Hg was found in 37.0% of those with A-subtype compared with 12.0% of those with B-subtype infection (relative risk=3.08; p=0.04). In discrete multivariate (logit) analysis, effects of subtype (odds ratio=6.59; p<0.01) on severity remained after adjustment for other statistically significant effects of age less than 3 months, underlying condition, and premature birth. The finding that A-subtype infections were more severe might have important implications for vaccine development, studies of the virulence of respiratory syncytial virus, clinical management (e.g., selection for antiviral therapy), and long-term prognosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3476
1097-6833
DOI:10.1016/S0022-3476(05)82443-6